A new kalium channel blocker of Chinese medicinal origin —Benzyltetrahydropalmatine hydrochloride

Abstract

Benzyltetrahydropalmatine hydrochloride (BTHP) exhibited antiarrhythmic action in animal models.

I. Electrophysiological effects of BTHP were investigated in various heart preparations.

1.	BTHP markedly prolonged functional refractory period and inhibited adrenaline-induced automaticity. It decreased spontaneously beating rate of right atrium and abolished ouabain-induced delayed afterdepolarization and triggered activity of papillary muscle.
2.	In standard microelectrode and contractility experiments BTHP concentrationdependently prolonged the action potential duration (APD) and effective refractory period (FRP) between 1–100 μmol/L, the force of contraction remained unchanged.
3.	In voltage clamp experiments BTHP 1–100 μmol/L inhibited in dose-dependent manner the Ik with IC50 of 13 μmol/L and inhibited also I5 at high concentration.
4.	In monophasic action potential (MAP) of feline ventricle MAPD50 and MAPD90 were prolonged by BTHP in normal myocardium, and shortened APD induced by ischemia and reperfusion was restored to normal level.
5.	In ECG and His-bundle electrogram heart rate was reduced; P-R and A-H interval were prolonged, but H-V interval and V duration were unaffected.

I. BTHP showed a competitive α₁-adrenoceptor-blocking effect with pA2 value of 5.8 and 5.86 in rat anococcygeus muscle and rabbit aortic strips respectively. Radioligand binding assays showed that BTHP had affinity for both α₁ and α₂-adrenoceptor.

The results from these experiments show that BTHP is a new K⁺ channel blocker of Chinese medicinal origin with α₁-adrenoceptor-blocking action.

Keywords

benzyltetrahydropalmatine hydrochloride / cardiac electrophysiology / α-adrenoceptor / tetrahydropalmatine / berbines / kalium channel blocker

References

[1] 1988, 17 : 118–121.

[2] 1990; 25(4): 303–6

[3] 1990; 11(2) : 141–3.

[4] 1989; 3 : 304–5.

[5] 1(4) : 263–7.

[6] 1988; 23(9) : 641–5.

[7] CarmerlietE. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther, 1985, 232: 817-25

[8] CookNS. Pharmacology of potassium channels and their therapeutic potential. Trends in Pharmacological Science (TIPS), 1988, 9: 21-8

[9] BacanerMB, et al. . Potassium channel blockade: a mechanism for suppressing ventricular fibrillation. Proc Natl Acad Sci USA, 1986, 83: 2223-7

[10] BolliR, et al. . Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. Am Heart J, 1986, 111: 261-70

[11] TosakiA, et al. . Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol, 1987, 10: 489-97